In vitro evaluation of the inhalation toxicity of the cosmetic ingredient aluminum chlorohydrate

J Appl Toxicol. 2022 Dec;42(12):2016-2029. doi: 10.1002/jat.4371. Epub 2022 Aug 1.

Abstract

Aluminum chlorohydrate (ACH) is a major aerosol component frequently used as the active ingredient in antiperspirants, and in vivo studies have raised a concern about its inhalation toxicity. Still, few studies have addressed its effects on the human respiratory tract. Therefore, we developed a study on ACH inhalation toxicity using an in vitro human alveolar cell model (A549 cells) with molecular and cellular markers of oxidative stress, immunotoxicity, and epigenetic changes. The chemical characterization of ACH suspensions indicated particle instability and aggregation; however, side-scatter analysis demonstrated significant particle uptake in cells exposed to ACH. Exposure of A549 cells to non-cytotoxic concentrations of ACH (0.25, 0.5, and 1 mg/ml) showed that ACH induced reactive oxygen species. Moreover, ACH upregulated TNF, IL6, IL8, and IL1A genes, but not the lncRNAs NEAT1 and MALAT1. Finally, no alterations on the global DNA methylation pattern (5-methylcytosine and 5-hydroxymethylcytosine) or the phosphorylation of histone H2AX (γ-H2AX) were observed. Our data suggest that ACH may induce oxidative stress and inflammation on alveolar cells, and A549 cells may be useful to identify cellular and molecular events that may be associated with adverse effects on the lungs. Still, further research is needed to ensure the inhalation safety of ACH.

Keywords: epigenetic changes; human alveolar cell line; immunotoxicity; in vitro methods; inhalable cosmetics; oxidative stress.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Inhalation
  • Aerosols
  • Aluminum*
  • Cosmetics*
  • Humans
  • Inhalation Exposure / adverse effects
  • Pharmaceutical Vehicles

Substances

  • Aluminum
  • Cosmetics
  • Aerosols
  • Pharmaceutical Vehicles
  • aluminum chlorhydrate